1. Introduction {#sec1}
===============

Keratoconus is a chronic, progressive, noninflammatory ectatic corneal condition that leads to decreased visual acuity because of increased myopia and irregular astigmatism. These conditions are known to affect patients 18--40 years of age. The severity of the disease varies from a subclinical stage to a severely progressive stage, resulting in corneal scarring, perforation, or even blindness \[[@B1], [@B2]\]. Treatment also varies from wearing glasses or rigid contact lenses to complex surgical procedures such as keratoplasty to restore visual acuity \[[@B1]\].

The previously reported annual incidence of keratoconus varied greatly from 1.3 to 32.3 cases per 100,000, according to the country where the study was conducted \[[@B3]\]. This wide range of reported estimates may be due to ethnic differences, differences in accessibility because of regional differences, and discordant study designs \[[@B3]\]. Additionally, with recent advances in refractive surgery and the development of delicate corneal topographic devices and software, keratoconus is diagnosed more frequently than before, especially in the early subclinical stages, which may also account for some disparities in the estimates of annual incidence of keratoconus \[[@B4], [@B5]\].

While the pathophysiology of keratoconus is currently not clearly known, a few previous studies investigated risk factors for keratoconus to clarify its pathophysiological mechanism \[[@B4]\]. The reported risk factors for keratoconus include ocular allergy, atopic dermatitis, connective tissue disorders, and Down syndrome \[[@B6]--[@B9]\]. Contradictory results exist regarding the role of diabetes mellitus (DM) in the development of keratoconus, with the possibility of increasing or reducing the risk of developing corneal ectasia \[[@B10]--[@B12]\]. Considering ethnic differences in the incidence of keratoconus, possible associations between systemic comorbidities and keratoconus should be clearly determined in patients with Asian ethnicity, and reports regarding the risk factors for keratoconus in the Republic of Korea should be clearly defined.

Based on these considerations, we evaluated the incidence of keratoconus and investigated associations between various systemic conditions and keratoconus using data from a nationwide sample of approximately 1 million residents from the National Health Insurance Service-National Sample Cohort 2002--2013 (NHIS-NSC 2002-2013).

2. Methods and Materials {#sec2}
========================

2.1. Database {#sec2.1}
-------------

This study used data from the NHIS-NSC 2002--2013. The Korean National Health Insurance Service (KNHIS), which is a mandatory single medical insurer system, has been managing national health insurance in the Republic of Korea since 1989. All citizens are required to enroll in the system, and it provides nearly the entire healthcare coverage in the Republic of Korea. The KNHIS developed the NHIS-NSC for research purposes, which contains personal demographic records for all medical information related to insurance claims. The NHIS-NSC sampled 1,025,340 individuals from among 46,605,433 individuals in the NHID (2.2%) in 2002 and followed them until 2013 \[[@B13]\]. The study design was approved by the Institutional Review Board of Soonchunhyang University Bucheon Hospital, Gyeonggi-do, Republic of Korea. This study adhered to the tenets of the Declaration of Helsinki, and the need for written informed consent was waived.

2.2. Selection of Study Samples {#sec2.2}
-------------------------------

To exclude chronic keratoconus patients, we excluded patients who were diagnosed with keratoconus in 2002 and 2003 and included patients who were diagnosed with keratoconus from 2004. The keratoconus cases were identified as patients who had the following Korean Classification of Diseases code as the main diagnosis code: H186 and H198, and had a keratometry measurement code (E6870).

Control subjects were selected from individuals who did not have keratoconus diagnosis codes, each year, using propensity scores with nearest neighbor matching in a 1 : 5 ratio to keratoconus patients \[[@B14]\]. Propensity scores were calculated using sociodemographic parameters, including age group (≤19, 20--59, and ≥60 years of age), sex, income (≤40^th^, 41^st^--70^th^, and ≥71^st^ percentiles), residential area (urban, metropolitan cities, cities, rural, and all other areas), and year of enrollment.

2.3. Incidence and Comorbidity {#sec2.3}
------------------------------

In the matched populations, we compared the incidence of keratoconus. The earliest date of the keratoconus diagnosis was defined as the index date and the incident time, and the patient was considered an incident case in that corresponding year. Comorbid conditions included allergic rhinitis (codes), asthma (codes), atopic dermatitis (codes), aortic dissection (codes), sleep apnea (codes), collagen vascular diseases (codes), DM (codes E10--E14), mitral valve prolapse (codes), and Down syndrome (code) that were diagnosed between 2002 and 2008. Because the purpose of this study was to investigate associations between systemic diseases and keratoconus, and not necessarily to identify causative relationships between the conditions, we included cases and controls without considering the date when the diagnosis was made during the study period.

2.4. Statistical Analysis {#sec2.4}
-------------------------

Baseline characteristics are expressed as the mean and standard deviation or number and percentage. The chi square test was used to compare groups. Multivariate logistic regression analysis was performed to calculate odds ratio (OR) with a 95% confidence interval (CI) to evaluate the potential association between keratoconus and various systemic diseases. The variables included in multivariate analyses were age, sex, income, residential area, and systemic diseases of interest that were previously reported to be associated with keratoconus. All statistical analyses were conducted using SAS software, version 9.4 (SAS Institute, Cary, NC, USA), and R 3.4.1 (R Project for Statistical Computing, Vienna, Austria).

3. Results {#sec3}
==========

The number of patients diagnosed with keratoconus from 2004 to 2013 came to 1,552, and 7,760 controls were included for comparison. The incident cases were 46 (4.5%), 30 (3.0%), 20 (2.0%), 40 (3.9%), 49 (4.9%), 76 (7.6%), 33 (3.3%), 48 (4.8%), 37 (3.7%), and 8 (0.8%) in 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, and 2013, respectively ([Table 1](#tab1){ref-type="table"} and [Figure 1](#fig1){ref-type="fig"}).

[Table 2](#tab2){ref-type="table"} shows the baseline characteristics of the study population. A total of 1,552 keratoconus patients and 7,760 subjects from the control group were included for analysis. There were no significant differences in demographic characteristics used for matching, including age group, sex, income, residential area, and the year of enrollment. Among the systemic diseases that were previously reported to be associated with keratoconus, allergic rhinitis (*p* \< 0.001), asthma (*p* \< 0.001), and atopic dermatitis (*p* \< 0.001) were more prevalent in the keratoconus group, while DM was more prevalent in the comparison group (*p* \< 0.001). Other diseases, including aortic dissection, sleep apnea, and collagen vascular diseases, did not show any significant difference between groups. Mitral valve prolapse and Down syndrome were excluded for further analysis because the prevalence in both groups was not measurable or very low.

Using multivariate logistic regression analysis, individuals with allergic diseases, including allergic rhinitis (OR: 1.86; 95% CI: 1.63--2.13; *p* \< 0.001), asthma (OR: 1.20; 95% CI: 1.06--1.36; *p*=0.005), and atopic dermatitis (OR: 1.33; 95% CI: 1.13--1.56; *p* \< 0.01), had significant associations with keratoconus after adjusting for confounding factors ([Table 3](#tab3){ref-type="table"}). However, aortic dissection and sleep apnea did not show a significant association with higher or lower odds of keratoconus. Keratoconus also showed a significantly positive association with DM (OR: 1.35; 95% CI: 1.15--1.58; *p* \< 0.001). No significant association was found for demographic factors because they were used for propensity matching.

4. Discussion {#sec4}
=============

In the present study, the incidence rate of keratoconus ranged from 0.8 to 7.5 per 100,000 person-years during 2004 and 2013. After propensity score matching, logistic regression analysis showed significant associations with the presence of allergic rhinitis, asthma, and atopic dermatitis. However, no relevant result appeared in systemic diseases such as aortic dissection, sleep apnea, collagen vascular diseases, mitral valve prolapse, and Down syndrome.

Lee et al. \[[@B15]\] studied the epidemiology of keratoconus, which was designed in a similar manner but showed different results compared to our results. In contrast to our results, allergic conjunctivitis was the only risk factor for keratoconus in the Republic of Korea population in their study. Importantly, allergic rhinitis was not a risk factor for keratoconus, which differed from other studies, including our results. We suggest the difference in results was because their databases were from 2002 and 2015. They also used only age and household income for propensity scores, while in this study, we included age, sex, income, residential area, and year of enrollment to exclude any potential confounding factors that may affect the outcome. Additional studies are needed to confirm the results of various studies.

An epidemiological study from Germany reported that the incidence of keratoconus per 100,000 person-years was 13.3 (1 : 75,000), which showed a high incidence rate compared to our study \[[@B16]\]. The reason for this disparity may be due to the diagnostic codes, which may have included other conditions, as well as regional and racial differences among the patients included in the study. Another previously reported study in the Republic of Korea, which was a population-based study using the Korean Health Insurance Review and Assessment database, reported an incidence of keratoconus of 5.56 cases per 100,000 person-years \[[@B17]\], which was similar to the result from our study.

The conclusions reached in our study showed a significant association between allergic diseases including allergic rhinitis, asthma, atopic dermatitis, and the presence of keratoconus. An earlier study also reported that atopic diseases including asthma, vernal keratoconjunctivitis, atopic keratoconjunctivitis, and seasonal or perennial allergic keratoconjunctivitis were associated with keratoconus, and their prevalence in keratoconus patients had a higher incidence than the control group \[[@B18]\]. The most common cause of keratoconus is thought to be frequent eye rubbing, and pruritis associated with atopy and other allergic conditions leads to eye rubbing \[[@B19]--[@B24]\]. As a result of mechanical rubbing, friction occurs between the palpebral conjunctiva and corneal epithelium, which may eventually lead to corneal thinning, finally resulting in tissue bulging and a cone-shaped structure. Another possible theory suggests that the association between keratoconus and an allergic condition involves activation of the same human leukocyte antigens \[[@B19]\].

Importantly, our study showed a positive association between keratoconus and DM. Regarding the association between keratoconus and DM, there are several studies that have reported patient groups with DM showing lower odds of having keratoconus, when compared to groups without diabetics, with reduced odds ranging from 20% to 78% \[[@B10], [@B25], [@B27]\]. Studies reporting a low incidence of keratoconus in diabetics suggested that the results were due to thicker corneas in patients with diabetics. There are two hypotheses regarding the high stromal volume in diabetics. First, Ishino et al. \[[@B28]\] investigated corneal autofluorescence using a fluorophotometer and found that corneal autofluorescence in diabetics was higher than that of controls. They suggested mitochondrial dysfunction, water retention in the stroma, and increased corneal volume after observing the corneal autofluorescence. Another hypothesis suggested that high glucose levels stimulate nonenzymatic glycosylation, which leads to collagen cross-linking, stromal strengthening, and the prevention of age-related thinning \[[@B28]\]. However, Kosker et al. reported contradictory results in their case-control study, showing that patients with DM were more likely to suffer from keratoconus compared to normal controls \[[@B12]\]. The results of the present study are consistent with those of Kosker et al., showing a significant positive association between keratoconus and DM. However, further studies with a similar design are needed to confirm these results.

We also investigated the association between keratoconus and other systemic comorbidities, which were previously reported to be related with the disease. Previous studies have reported higher odds of keratoconus in patients with Down syndrome, mitral valve prolapse, collagen vascular disease, and sleep apnea \[[@B28]--[@B30]\]. However, the number of patients with these conditions was very low or absent in the cohort used for the analysis, so associations could not always be determined. Further studies with more patients are needed, therefore, to confirm the results.

The present study, based on reliable and numerous population groups, supported the positive correlation of keratoconus and allergic diseases. This study is one of the few studies that has investigated the epidemiology of keratoconus in the Korean population. However, there were some limitations to our study. The prevalence of keratoconus was lower than expected in some diseases, especially in mitral valve prolapse and Down syndrome, so the necessity of better-designated control groups is indicated. Moreover, it suggests the need for further investigations regarding other parameters, such as eye rubbing or sleep positions.

There are several limitations to consider when interpreting the results of our study. First, the diagnosis of keratoconus was entirely based on the KCD code system which may be inaccurate compared to the diagnosis made with a standardized diagnostic measurement. To overcome such limitations, we included those who had diagnostic code for keratoconus and underwent keratometry measurement, which may enhance the specificity of the keratoconus subjects included in this study. Second, it is possible that the OAG patients may have been underestimated because the data are based on hospital visits. The data do not include initial patients who did not experience symptoms and patients who do not visit the hospital for economic reasons. However, the degree of underestimation is limited due to the low cost and high accessibility of the Korean medical system, a government-run healthcare system including nearly the entire population of South Korea. Therefore, it is unlikely that inaccuracy and underestimation of the diagnosis affected the statistical results. Third, our data include only data for the Korean population, and there may be differences in other ethnic groups.

In summary, statistical analysis showed a significant association between keratoconus and atopic diseases such as allergic rhinitis, asthma, and atopic dermatitis. Considering the incidence of keratoconus with the above comorbid conditions, studies investigating this association may help in the planning of eye-care policies. However, conflicting results regarding the possible association between keratoconus and DM should be further evaluated.
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###### 

Estimated incidence rate (per 100,000 person-years) of keratoconus in South Korea during 2004--2013.

  Year            2004        2005        2006        2007        2008        2009      2010        2011        2012        2013
  --------------- ----------- ----------- ----------- ----------- ----------- --------- ----------- ----------- ----------- -----------
  Population      1,016,391   1,016,646   1,001,891   1,020,593   1,000,601   998,348   1,001,898   1,006,332   1,011,013   1,014,622
                                                                                                                            
  Incidence       46          30          20          40          49          76        33          48          37          8
                                                                                                                            
  (per 100,000)   4.5         3.0         2.0         3.9         4.9         7.6       3.3         4.8         3.7         0.8

###### 

Characteristics of study population.

  Total                        Keratoconus patients (*N*, %)   Matched control (*N*, %)   Total   *p* value           
  ---------------------------- ------------------------------- -------------------------- ------- ----------- ------- ---------
  Allergic rhinitis                                                                                                   
   No                          342                             22.0                       2,810   36.2        3,152   \<0.001
   Yes                         1,210                           78.0                       4,950   63.8        6,160    
                                                                                                                      
  Asthma                                                                                                              
   No                          1,048                           67.5                       5,833   75.2        6,881   \<0.001
   Yes                         504                             32.5                       1,927   24.8        2,431    
                                                                                                                      
  Atopic dermatitis                                                                                                   
   No                          1,296                           83.5                       6,858   88.4        8,154   \<0.001
   Yes                         256                             16.5                       902     11.6        1,158    
                                                                                                                      
  Aortic dissection                                                                                                   
   No                          1,550                           99.9                       7,753   99.9        9,303   0.655
   Yes                         2                               0.1                        7       0.1         9        
                                                                                                                      
  Sleep apnea                                                                                                         
   No                          1,548                           99.7                       7,746   99.8        9,294   0.527
   Yes                         4                               0.3                        14      0.2         18       
                                                                                                                      
  Collagen vascular diseases                                                                                          
   No                          1,550                           99.9                       7,754   99.9        9,304   0.527
   Yes                         2                               0.1                        6       0.1         8        
                                                                                                                      
  Diabetes mellitus                                                                                                   
   No                          1,254                           80.8                       6,636   85.5        7,890   \<0.001
   Yes                         298                             19.2                       1,124   14.5        1,422    
                                                                                                                      
  Mitral valve prolapse                                                                                               
   No                          1,552                           100.0                      7,757   100.0       9,309   0.439
   Yes                         ---                             0.0                        3       0.0         3        
                                                                                                                      
  Down syndrome                                                                                                       
   No                          1,552                           100.0                      7,759   100.0       9,311   0.655
   Yes                         ---                             0.0                        1       0.0         1        
                                                                                                                      
  Variables for matching                                                                                              
                                                                                                                      
  Sex                                                                                                                 
  Male                         678                             43.7                       3,390   43.7        4,068   1.000
  Female                       874                             56.3                       4,370   56.3        5,244    
                                                                                                                      
  Age group                                                                                                           
  ≤19                          233                             15.0                       1,165   15.0        1,398   1.000
  20--59                       1,045                           67.3                       5,225   67.3        6,270    
  ≥60                          274                             17.7                       1,370   17.7        1,644    
                                                                                                                      
  Income                                                                                                              
  Low                          302                             19.5                       1,510   19.5        1,812   1.000
  Middle                       554                             35.7                       2,770   35.7        3,324    
  High                         696                             44.8                       3,480   44.8        4,176    
                                                                                                                      
  Residential area                                                                                                    
  Metropolitan                 130                             8.4                        650     8.4         780     1.000
  City                         401                             25.8                       2,005   25.8        2,406    
  Rural                        1,021                           65.8                       5,105   65.8        6,126    

###### 

Logistic regression model estimating associations of covariates with keratoconus.

  Variables                    Odds ratio (95% CI)   *p* value           
  ---------------------------- --------------------- ------------------- ---------
  Allergic rhinitis            No                    1.000 (reference)    
                               Yes                   1.86 (1.63--2.13)   \<0.001
                                                                         
  Asthma                       No                    1.000 (reference)    
                               Yes                   1.20 (1.06--1.36)   0.005
                                                                         
  Atopic dermatitis            No                    1.000 (reference)    
                               Yes                   1.33 (1.13--1.56)   \<0.001
                                                                         
  Aortic dissection            No                    1.000 (reference)    
                               Yes                   1.17 (0.24--5.75)   0.853
                                                                         
  Sleep apnea                  No                    1.000 (reference)    
                               Yes                   1.28 (0.42--3.92)   0.675
                                                                         
  Collagen vascular diseases   No                    1.000 (reference)    
                               Yes                   1.31 (0.26--6.65)   0.751
                                                                         
  Diabetes mellitus            No                    1.000 (reference)    
                               Yes                   1.35 (1.15--1.58)   \<0.001
                                                                         
  Variables for matching                                                  
                                                                         
  Sex                          Male                  1.000 (reference)    
                               Female                0.92 (0.82--1.03)   0.135
                                                                         
  Age group                    ≤19                   1.000 (reference)    
                               20--59                1.15 (0.97--1.36)   0.092
                               ≥60                   1.01 (0.81--1.26)   0.495
                                                                         
  Income                       Low                   1.000 (reference)    
                               Middle                0.98 (0.84--1.15)   0.831
                               High                  0.94 (0.80--1.09)   0.337
                                                                         
  Residential area             Metropolitan          1.000 (reference)    
                               City                  0.95 (0.77--1.19)   0.756
                               Rural                 0.96 (0.78--1.17)   0.744
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